Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/1998
03/12/1998CA2265889A1 E25a protein, methods for production and use thereof
03/12/1998CA2265883A1 Iron regulated promoter and uses thereof
03/12/1998CA2265470A1 Biochemical markers of the human endometrium
03/12/1998CA2265251A1 Cell-based drug screens for regulators of gene expression
03/12/1998CA2265249A1 Preparation of purified (poly)peptides
03/12/1998CA2264968A1 Humanized immunoglobulin reacting specifically with fas ligand or active fragments thereof and region inducing apoptosis originating in fas ligand
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264956A1 Herpesvirus saimiri as viral vector
03/12/1998CA2264955A1 Cloning of full-length human pex cdna
03/12/1998CA2264845A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998CA2264677A1 Adenylosuccinate synthetase
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264499A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998CA2264493A1 Human homolog of the latheo gene
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264489A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998CA2264486A1 Non-iga fc binding forms of the group b streptococcal beta antigens
03/12/1998CA2264485A1 Gata-6 transcription factor: compositions and methods
03/12/1998CA2264482A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
03/12/1998CA2264481A1 Materials and methods for increasing corn seed weight
03/12/1998CA2264273A1 Human cns cell lines and methods of use therefor
03/12/1998CA2261703A1 Electroporation employing user-configured pulses
03/12/1998CA2259969A1 Phospholipase d and dna sequences
03/12/1998CA2259959A1 Modulators of brca1 activity
03/12/1998CA2236770A1 Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein
03/12/1998CA2235630A1 Materials and methods for detecting fungi
03/11/1998EP0828006A2 Use of cis- and/or trans-elements to enhance the efficiency of parvoviral vector transduction, integration and/or transgene expression
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0828004A2 Protein disulfide isomerase gene derived from strain of methylotrophic yeast
03/11/1998EP0828003A2 Human serine protease
03/11/1998EP0828002A2 Modification of xylanase to improve thermophilicity, alkophilicity and thermostability
03/11/1998EP0827966A1 Preparation of purified (poly) peptides
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827547A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
03/11/1998EP0827546A2 Gene therapy using replication competent targeted adenoviral vectors
03/11/1998EP0827545A2 Retroviral vectors
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827543A1 Production of 1,3-propanediol from glycerol by recombinant bacteria expressing recombinant diol dehydratase
03/11/1998EP0827542A1 Application of glucose transport mutants for production of aromatic pathway compounds
03/11/1998EP0827541A1 A method and nucleotide sequence for transforming microorganisms
03/11/1998EP0827540A1 Transgenic animal models for type ii diabetes mellitus
03/11/1998EP0827539A2 Kunitz type protease inhibitors
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/11/1998EP0827537A2 Chromatin-regulator genes
03/11/1998EP0827536A1 A method for large scale plasmid purification
03/11/1998EP0827532A1 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid
03/11/1998EP0827531A2 Subtilisin variants
03/11/1998EP0827512A1 ANTIBODY SPECIFIC FOR $i(STAPHYLOCOCCUS AUREUS), AND USE THEREOF
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998EP0827508A2 Soluble, cleavable substrates of the hepatitis c virus protease
03/11/1998EP0827410A1 Method for introducing and expressing genes in animal cells
03/11/1998EP0759070A4 Blood-borne mesenchymal cells
03/11/1998EP0717779A4 Method and device for detection of nucleic acid or analyte using total internal reflectance
03/11/1998EP0656785B1 Method for inhibiting hiv replication using il-4
03/11/1998EP0646180A4 Methods for inactivating nucleotide sequences and metal chelates for use therein.
03/11/1998EP0556178B1 Use of protease nexin-i to mediate wound healing
03/11/1998EP0503002B1 Antisense oligonucleotide inhibition of papillomavirus
03/11/1998CN1175977A Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecule HLA-Cw* 1601 and uses thereof
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175956A Novel protein and method for production of same
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/11/1998CN1175639A Construction of illuminating protein gene vector and illuminating gene immune diagnostic reagent
03/11/1998CN1175638A Process for construction and purifying of recombinant human lymph toxin alpha deriv. a
03/11/1998CN1175637A Expression of human hepatitis C virus protein in engineering bacteria and use of expression protein
03/11/1998CN1175586A Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof
03/11/1998CN1175585A Double antigen contg hepatitis B virus and hepatitis C virus core antigen simultaneously
03/10/1998US5726299 Promoter DNA fragment from coryneform bacteria
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726290 Soluble analogues of integrins
03/10/1998US5726222 Microcapsule-type curing agent, method for producing the same, thermosetting resin composition, prepreg and fiber reinforced composite material
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726059 Cells of rna molecules and polypeptides for sequences
03/10/1998US5726057 Nucleotide sequences for genes
03/10/1998US5726053 Recombinant Zymomonas for pentose fermentation
03/10/1998US5726051 Transglutaminase gene
03/10/1998US5726045 Materials and methods for converting DNA to CO-DNA
03/10/1998US5726044 Expression and export technology of proteins as immunofusins
03/10/1998US5726043 Process for the production of protease inhibitors
03/10/1998US5726042 Expression of heterologous proteins in Bacillus megaterium utilizing sporulation promoters of Bacillus subtilis
03/10/1998US5726041 Method for detecting a receptor-ligand complex using a cytochrome P450 reporter gene
03/10/1998US5726039 Vectors and transformed host cells for recombinant protein production at reduced temperatures
03/10/1998US5726038 DNA construct encoding the YAP3 signal peptide
03/10/1998US5726037 Host cells and method of producing soluble analogues of integrins
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726035 Recombinant production of mammalian calcium channel gamma subunits
03/10/1998US5726032 Process for the efficient production of 7-ADCA via 2-(carboxyethylthio)acetyl-7-ADCA and 3-(carboxymethylthio)propionyl-7-ADCA
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5726022 Subtractive hybridization and capture methods and kits for differential isolation of nucleic acids including disease-associated sequences
03/10/1998US5726021 Pretreating cells by enzyme degradation, magnesium chelators, nonionic and anionic detergents and heating
03/10/1998US5726020 Inhibition of II synthesis
03/10/1998US5726017 High affinity HIV-1 gag nucleic acid ligands
03/10/1998US5726014 Screening assay for the detection of DNA-binding molecules
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/10/1998US5725858 Methods of enhancing production performance of birds comprising administration of heterologous protein comprising avian alpha-subunit inhibin protein
03/10/1998US5725850 Use of CSF-1 to treat tumor burden
03/10/1998US5725831 Nucleic acid amplification apparatus
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/06/1998CA2209890A1 Apoptotic agents for tumor cells of the nervous system
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
1 ... 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 ... 4023